Neonious Biotech

Neonious Biotech

Created using Figma
Neonious Biotech is introducing the Neonious Token (MDSIM) which is intended to
incentivize large numbers of people to form the Neonious Network, a group of
computers which will perform the molecular dynamics simulations, by distributing
newly generated MDSIMs among these people based on the computing power they
provide to the cause. With the molecular dynamics simulations, Neonious Biotech
will power Alzheimer and dementia research.
Pre-ICO
25 may 2021
31 oct 2021
100% terminado
Fondos recaudados - sin datos
Gol 250 000.00 USD
Gorra 30 000 000.00 USD
past
  • 1 MDSIM
    =
    0.1 USD
Detalles del token
Corazón
MDSIM
Suministro total
125000000
Distribución de fichas
80% Token Sale
11% Token Sale Marketing
6% Scientific Advisors
3% Neonious Employees
Monedas aceptadas
ETH, USDC
Contribución mínima
250000
USD
Detalles de la compañía
Nombre de la empresa registrada
Neonious Biotech
País registrado
Germany
Estructura de bonificación
The price per token starts at 0.10 USD and will, as a minimum, increase by 0.01 USD after every 250,000 ordered tokens, making it worthwhile to buy early.
Detalles adicionales
MVP / Prototipo
Plataforma
Ethereum
Países restringidos
Cuba, Iran, Lebanon, Libya, Syria, Sudan, Yemen
Categorías
Plataforma

Acerca de Neonious Biotech

We are pioneers of in silico prediction of drug safety and adverse reactions, limiting cost risks and reducing harm done to animals and humans.

To have the best tools for our drug analysis, we constantly optimize algorithms and pipelines and grow our distributed network which is a cost-efficient source for the needed computing power.

Our research is powered by the Neonious Network
and the Neonious Token (MDSIM).

Neonious is contracted to help to assess a drug for safety and adverse reactions.

Besides manual analysis, Neonious' research team utilizes computational pipelines

These pipelines queue simulations (docking + MD) to be run by the Neonious Network, paid with MDSIMs.

Sombody running the Neonious software, thus being part of the Neonious Network, runs the simulations.

This person is rewarded with easy transferable MDSIMs, which he or her can exchange for real money.

We believe it is beneficial to reduce risks by contract us to analyse your drug, preferable before starting preclinical research, latest before phase 2 of the human trials.

For lower cost, we can utilize the Neonious Network. Alternatively, the calculations can also be done on more private computing resources

Información técnica

https://github.com/neonious/WelcomeToCodeRepository

Neonious Biotech Roadmap

  • 25/05/2021

  • Neonious Tokens can be ordered at the Neonious Biotech website. The earlier they are
    ordered, the cheaper the tokens are.
  • 01/07/2021

  • Extensively tested Neonious MD software available on GitHub (source code) and for
    download (Windows, macOS and Linux). May be used on testing network to generate new
    testing tokens.
  • 01/09/2021

  • Neonious MD software and mining contract passed security audit, results are published.
    Neonious Biotech starts the full ICO, preferably with a major exchange.
  • 31/10/2021

  • Neonious Token sale ends. Neonious Biotech will enable trading of Neonious Tokens for
    anyone on Uniswap by setting up an adequate liquidity pool.
  • Lee mas
  • 01/11/2021

  • Neonious Biotech will start helping people set up their systems with the Neonious MD
    software to scale the Neonious Network.
  • 01/01/2022

  • Start of actual molecular dynamic simulations targeting dementia.
  • Early 2022

  • We plan to have reached an agreement for the Neonious Token to be listed at a major
    exchange.

Neonious Biotech Equipo

Verificado 0%

Atención. Existe el riesgo de que los miembros no verificados no sean realmente miembros del equipo

Thomas Rogg
Chief Executive Officer & Head of Development Team
inconfirmado
Elena Elgina
Head of PR & Marketing
inconfirmado
Maria Cristina Fadgy...
Head of Scientific Affairs
inconfirmado
Martin Kämpf
Head of Digital Assets
inconfirmado

Neonious Biotech Últimas noticias

  • Debido a que puede haber diferencias de tiempo en las actualizaciones de información, la información precisa sobre cada proyecto ICO debe verificarse a través de su sitio web oficial u otros canales de comunicación.
  • Esta información no es una sugerencia o consejo para invertir en fondos de la OIC. Por favor, investigue a fondo la información relevante y decida la participación de la OIC.
  • Si cree que hay problemas o correcciones a corregir en este contenido, o si desea enviar su propio proyecto ICO para que aparezca en la lista, por favor envíenos un correo electrónico.
Lea la exención de responsabilidad y la advertencia de riesgo. Mostrar descargo de responsabilidad y advertencia de riesgo.